表位
重组DNA
计算生物学
生物分子
化学
抗原
纳米技术
计算机科学
生物
生物化学
免疫学
材料科学
基因
作者
Gholamreza Hassanzadeh‐Ghassabeh,Nick Devoogdt,Pieter De Pauw,Cécile Vincke,Serge Muyldermans
出处
期刊:Nanomedicine
日期:2013-06-01
卷期号:8 (6): 1013-1026
被引量:283
摘要
Nanobodies are recombinant, antigen-specific, single-domain, variable fragments of camelid heavy chain-only antibodies. The innate supremacy of nanobodies as a renewable source of affinity reagents, together with their high production yield in a broad variety of expression systems, minimal size, great stability, reversible refolding and outstanding solubility in aqueous solutions, and ability to specifically recognize unique epitopes with subnanomolar affinity, have combined to make them a useful class of biomolecules for research and various medical diagnostic and therapeutic applications. This article speculates on a number of technological innovations that might be introduced in the nanobody identification platform to streamline the generation of more potent nanobodies and to expand their application range.
科研通智能强力驱动
Strongly Powered by AbleSci AI